Hyperglykæmi Der er rapporteret nyopstået diabetes mellitus, hyperglykæmi og forværring af eksisterende diabetes mellitus hos patienter i behandling med proteasehæmmere.
Hyperglycaemia New onset diabetes mellitus, hyperglycaemia, and exacerbation of existing diabetes mellitus have been reported in patients receiving protease inhibitors.